| Members |
targetComponentId |
| infection aiguë des voies respiratoires supérieures de sites multiples |
Acute upper respiratory infection |
| Acute vesicular eczema of hands and/or feet |
Acute vesicular eczema of hand (disorder) |
| Acute vesicular eczema of hands and/or feet |
Acute vesicular eczema of foot |
| Acute vesicular emphysema |
Pulmonary emphysema |
| bronchite sifflante aiguë |
Bronchitis co-occurrent with acute wheeze (disorder) |
| bronchite sifflante aiguë |
Acute bronchitis co-occurrent with wheeze |
| Acute yellow atrophy |
Atrophy of liver |
| Acute yellow atrophy |
Acute necrosis of liver |
| Acute yellow atrophy |
Steatosis of liver |
| Acute-on-chronic vesicular eczema of hands and/or feet |
Acute-on-chronic vesicular eczema of hands (disorder) |
| Acute-on-chronic vesicular eczema of hands and/or feet |
Acute-on-chronic vesicular eczema of feet (disorder) |
| Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute bronchitis (disorder) |
| Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute tracheobronchitis |
| Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute bronchitis (disorder) |
| Acute: [bronchitis] or [chest infections] or [tracheobronchitis] |
Acute tracheobronchitis |
| Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] |
Acute cervical adenitis |
| Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] |
Acute lymphadenitis |
| Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] |
Acute abscess lymph node |
| Acyclovir 200mg/5mL s/f suspension |
Product containing precisely aciclovir 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Adalimumab 40mg injection solution 0.8mL prefilled syringe |
Adalimumab 50 mg/mL solution for injection |
| Adalimunab 40mg/mL injection solution 1mL prefilled syringe |
Adalimumab 50 mg/mL solution for injection |
| Adapalene 0.1% lotion |
Adapalene 1 mg/mL cutaneous lotion |
| Adapalene 0.1% solution |
Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Added in error: [FP22] or [GP22] |
Patient deregistration status |
| Added in error: [FP22] or [GP22] |
Patient deregistration status |
| Adder venom |
Puff adder venom |
| Adder venom |
Vipera berus venom (substance) |
| Addison's disease |
Addison's disease |
| Addison's disease |
Addison melanoderma |
| Additional behavior finding |
Behavior finding |
| Additional swelling / lump observation |
Mass of body structure |
| Additional swelling / lump observation |
Swelling |
| Adduction test |
Adduction test of knee |
| Adearcoma |
Adenosarcoma |
| Adenocarcinoma of colon |
Carcinoma of colon |
| Adenocarcinoma of colon |
Primary malignant neoplasm of colon |
| Adenoid implantation |
Implantation procedure (procedure) |
| Adenoid implantation |
Procedure on adenoids |
| Adenosine 3mg/mL injection |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| adénosine 3 mg/mL, flacon de 2 mL de solution pour injection |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Adenosine deaminase superactivity |
Constitutional aplastic anemia |
| Adenosine deaminase superactivity |
Hereditary nonspherocytic hemolytic anemia due to increased adenosine deaminase activity (disorder) |
| Adenosine deaminase superactivity |
Congenital hypoplastic anemia |
| Adenotome blade, reusable |
Surgical blade |
| Adenotome blade, single-use |
Surgical blade |
| Adenovirus (& infection) |
Family Adenoviridae (organism) |
| Adenovirus antibody level |
Measurement of adenovirus antibody (procedure) |
| Adequate anesthesia |
General anesthesia - under adequate anesthesia (finding) |
| Adhesiolysis (& peritoneal) |
Lysis of adhesions |
| Adhesion of male pelvis |
Adhesion of pelvis (disorder) |
| Adhesions and disruptions of iris and ciliary body |
Disruption of ciliary body (disorder) |
| Adhesions and disruptions of iris and ciliary body |
Adhesion of ciliary body (disorder) |
| Adhesions and disruptions of iris and ciliary body |
Disruption of iris (disorder) |
| Adhesions and disruptions of iris and ciliary body |
Adhesions of iris |
| Adhesions and disruptions of iris and ciliary body NOS |
Adhesions of iris |
| Adhesions and disruptions of iris and ciliary body NOS |
Disruption of ciliary body (disorder) |
| Adhesions and disruptions of iris and ciliary body NOS |
Adhesion of ciliary body (disorder) |
| Adhesions and disruptions of iris and ciliary body NOS |
Disruption of iris (disorder) |
| Adhesive 22.5cmx10cmx5mm thick felt |
Adhesive felt |
| Adhesive capsulitis of shoulder |
Adhesive capsulitis of shoulder (disorder) |
| Adhesive capsulitis of shoulder |
Scapulohumeral fibrositis |
| Adhesive felt 10.5cm x 8.3cm x 5mm |
Adhesive felt |
| Adhesive/bandage/suture, device |
Bandage |
| Adhesive/bandage/suture, device |
Adhesive plaster |
| Adhesive/bandage/suture, device |
Suture (physical object) |
| Adiposa cornea dystrophy |
Reis-Bucklers' corneal dystrophy |
| Adiposa cornea dystrophy |
Fatty degeneration of cornea |
| Adiposity |
Simple obesity (disorder) |
| Adiposity |
Obesity (disorder) |
| Adiposity |
Obesity (disorder) |
| Adiposity |
Simple obesity (disorder) |
| Adiposity |
Obesity (disorder) |
| Adiposity |
Simple obesity (disorder) |
| ajustement d'une prothèse ou d'un appareil maxillofacial |
Adjust mandibular resection prosthesis |
| ajustement d'une prothèse ou d'un appareil maxillofacial |
Adjust extraoral maxillofacial prosthesis |
| Adjustment |
Adjustment (attribute) |
| Adjustment |
Adjustment (procedure) |
| Adjustment reaction NOS |
Adjustment disorder |
| Adjustment to: [skeletal traction] or [Kirschner wire] |
Adjustment to Kirschner wire (procedure) |
| Adjustment to: [skeletal traction] or [Kirschner wire] |
Adjustment to skeletal traction of bone |
| Adjuvant |
Immunologic adjuvant (substance) |
| Adjuvant |
Freund's adjuvant |
| Adjuvant |
Incomplete adjuvant |
| Administration of botulism antitoxin |
Administration of botulism antitoxin (procedure) |
| Administration of botulism antitoxin |
Injection of botulism antitoxin (procedure) |
| Administration of botulism antitoxin |
Infusion of botulism antitoxin (procedure) |
| Administration of cancer treatment |
Administration of antineoplastic agent |
| Administration of cancer treatment |
Administration of antineoplastic agent |
| Administration of cancer treatment |
Administration of antineoplastic agent |
| Administration of eye drugs -[no drugs here] |
Applying medication to eyes |
| Administration of eye drugs -[no drugs here] |
Instilling eye drops |
| Administration of human papilloma virus type 4 vaccine |
Administration of vaccine product containing only Human papillomavirus 6, 11, 16 and 18 antigens (procedure) |
| Administration of oral typhoid live vaccine |
Administration of live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product via oral route |
| Administration of pneumococcal 7-valent conjugate vaccine |
Administration of pneumococcal 7-valent conjugate vaccine |
| Administration of pneumococcal polysaccharide 23 valent vaccine |
Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
| Administration of saline solution |
Intra-arterial infusion of saline |
| Administration of saline solution |
Infusion of saline solution |
| Administration of steroid |
Infusion of steroid |
| Administration of steroid |
Administration of steroid |
| Administration of steroid |
Injection of steroid |
| Administration of subcutaneous zoster virus live vaccine |
Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route |
FHIR